Ferulic acid derived from Huanshaodan improves cognitive deficits in Alzheimer's disease model through regulating APP proteolytic processing via downregulation of SIRT2 expression

待确认 10 由云溪发布于 2026/1/24 17:57:43

DOI:10.1016/j.jep.2025.120508
作者：Yunfang Su , Congcong Shang , Bing Cao, Huifen Ma, Pan Wang, Junying Song, Zhishen Xie, Zhenqiang Zhang
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Ethnopharmacological relevanceHuanshaodan (HSD) is a Traditional Chinese Medicine Compound Prescription, traditionally used in the clinical treatment of Alzheimer's disease (AD) in China. Ne

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

8小时前

ming18

8b0be2f7f90c11f0afa034735aa3bc31.pdf

8小时前

Book学术机器人

2026/1/24 17:57:43 未找到该文献，机器人已退出，请等待人工下载

2026/1/24 17:57:43 Book学术AI机器人收到请求，开始寻找文献

2026/1/24 17:57:43 已向机器人发送请求

8小时前

云溪发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierProcessing suitability of three tilapia species as alternative freshwater surimi: A comprehensive evaluation from muscle physicochemical to gelling properties